Mr Stephen Velasquez, MSW, CISW, LCSW in Cave Springs, AR - Social Worker

Mr Stephen Velasquez, MSW, CISW, LCSW is a Social Worker based in Cave Springs, Arkansas. Mr Stephen Velasquez is licensed to practice in Virgin Island (license number 0-23249-1B) and his current practice location is 504 Rustic Creek Ln, Cave Springs, Arkansas. He can be reached at his office (for appointments etc.) via phone at (914) 768-6110.

NPI number for Mr Stephen Velasquez is 1982972584 and his current mailing address is 504 Rustic Creek Ln, Cave Springs, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1982972584.

Contact Information

	Mr Stephen Velasquez, MSW, CISW, LCSW
	504 Rustic Creek Ln, Cave Springs, AR 72718-8820
	(914) 768-6110
	Not Available

Healthcare Provider's Profile

Full Name	Mr Stephen Velasquez
Gender	Male
Speciality	Social Worker
Location	504 Rustic Creek Ln, Cave Springs, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1982972584
Provider Enumeration Date: 12/09/2011
Last Update Date: 01/19/2020

Medical Identifiers

Medical identifiers for Mr Stephen Velasquez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982972584	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	9830-C (Arkansas)	Secondary
104100000X	Social Worker	0-23249-1B (Virgin Island)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Stephen Velasquez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Stephen Velasquez, MSW, CISW, LCSW 504 Rustic Creek Ln, Cave Springs, AR 72718-8820 Ph: (914) 768-3026	Mr Stephen Velasquez, MSW, CISW, LCSW 504 Rustic Creek Ln, Cave Springs, AR 72718-8820 Ph: (914) 768-6110

News Archive

UNDT's 5-agent bioterrorism detection kits used by first responders

Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, issued a response today to a growing interest in the security and emergency response communities to immunize first responders most susceptible to anthrax exposure.

Researchers discover novel way to increase amounts of antibiotics

A novel way of increasing the amounts of antibiotics produced by bacteria has been discovered that could markedly improve the yields of these important compounds in commercial production. It could also be valuable in helping to discover new compounds. With the ever-growing threat from antibiotic resistance, these tools will be very useful in ensuring that we have enough of these useful compounds in the future.

Enrollment complete in Spectrum Pharmaceuticals' belinostat pivotal trial for PTCL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that it has achieved the target enrollment of the minimum of 100 evaluable relapsed or refractory peripheral T-cell lymphoma (PTCL) patients in the BELIEF registration trial.

First Edition: October 19, 2011

Now on Kaiser Health News' blog, Capsules, Marilyn Werber Serafini reports: "Medicare might fare better than other health care programs if the congressional super committee fails to agree on a deficit-reduction package and automatic cuts kick in, but even 2 percent is a big problem when it comes on top of other recent hits, warn Rick Pollack, executive vice president of the American Hospital Association, and Karen Ignagni, president of America's Health Insurance Plans."

New research center to expedite study of gene transfer approach

In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

Mr Stephen Velasquez, MSW, CISW, LCSW - Clinical Social Worker in Cave Springs, AR